Clostridioides difficile Research Team
University of South Florida
Dr. Sun is an Associate Professor with tenure in the Department of Molecular Medicine, College of Medicine at the University of South Florida (USF). He holds courtesy appointments in the Department of Internal Medicine, Department of Cell Biology, Microbiology & Molecular Biology, Department of Chemistry at USF, and USF Genomics. He received his PhD in Natural Sciences from the University of Kiel, Germany, and his Master Degree in Veterinary Microbiology and Immunology from the Nanjing Agricultural University, China. He received his postdoctoral training in Molecular Microbiology and Biochemistry at Brown University, USA. The research in his laboratory is focused on the pathogenesis of Clostridioides difficile and the development of novel therapeutics including vaccines to prevent / treat C. difficile infection (CDI). He was an NIH (National Institutes of Health) Career Development K01 Awardee. His laboratory has been continuously supported by the NIH. He has been actively serving NIH study section panels including chairing the NIH study section panel in 2020. He serves as an Associate Editor for “Molecular Medicine”, Associate Editor for “Frontiers in Microbiology”, and editorial boards for “Infection and Immunity” and “Applied and Environmental Microbiology”. He received Tufts Institute for Innovation Inaugural Award in 2014. In 2018, he was awarded "Faculty Outstanding Research Achievement Award" at USF. In 2020, he was awarded "Excellence in Innovation Award" at USF. He chaired the Research Committee of College of Medicine at USF from 2019 to 2020. He served as the Vice President for the USF Chapter, National Academy of Inventors, USA in 2022. Currently, he serves as the President for the USF Chapter, National Academy of Inventors.
Dr Sun profile: https://health.usf.edu/medicine/molecularmedicine/faculty/sun5
Lubem Agbendeh, MS
Justin is selected to the Judy Genshaft Honors College - University of South Florida, with a major in Biomedical Sciences in the 7-Year Accelerated BS/MD program. He works on vaccine prediction.
Dr. Tomatsidou is a Postdoctoral Fellow. She is well-trained in molecular microbiology, molecular biology and animal models of infectious diseases including CDI and COVID-19.
Marco is a undergraduate student from the Judy Genshaft Honors Colllege - USF with a major in Biomedical Sciences in the 7-year accelerated BS/MD program from honor college, and works on phage lysins and antigen prediction.
Dr. Wang is a Research Assistant Professor. He has a strong background in microbiology, molecular biology, protein expression and purification, infectious diseases with a focus on pathogenesis of C. difficile, animal models of C. difficile infection (CDI) and development of vaccines against CDI. He has published more than 50 scientific papers in peer reviewed journals.
Lauren Lapeter, BS
Hassan is a Graduate student in the Molecular Medicine Program. I am interested in the development of novel phage endolysins targeting C. difficile.
Anastasia Tomatsidou, PhD
Xingmin Sun, PhD (Principal Investigator)
Irene is a Graduate student in the Bioinformatics & Computational Biology program at USF and works on vaccine development against C. difficile infection using reverse vaccinology.
Shaohui Wang, PhD
Soumyadeep Chakraborty, PhD
Rajath Talpady, BS
Hassan Haidar, BS
Dr. Chakraborty is a Scientific Researcher. He has a strong background in molecular microbiology, molecular biology, protein engineering and expression with a recent focus on the pathogenesis of C. difficile and animal models of C. difficile infection. He was an Assistant Professor and the Department Head from 2018 to 2020 in the Department of Biotechnology & Bioinformatics, NIIT University, India.
Adrit is a undergraduate student from the Judy Genshaft Honors Colllege - USF with a major in Biomedical Sciences in the 7-year accelerated BS/MD program from honor college, and works on vaccine development using reverse vaccinology.
Lubem is a PhD student and is working on vaccine development against C. difficile infection using reverse vaccinology.